12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Clostridium Difficile vaccine: Phase III started

Sanofi's Sanofi Pasteur S.A. vaccines division began the single-blind, placebo-controlled, international Phase III Cdiffense trial to evaluate its C. difficile vaccine in up...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >